Neera Dahl, MD, PhD

• Abinet Aklilu
• Alan Dardik
• Allen Bale
• Cassius Iyad Ochoa Chaar
• E Kevin Hall
• Gilbert Moeckel
• Hamid Mojibian
• Justin Belcher
• Leslie Scoutt
• Margaret Bia
• Mohammad Abdullah Zafar
• Piruz Motamedinia
• Randy Luciano
• Stefan Somlo
• Tinika Montgomery
• TuKiet Lam
• Whitney Besse
• William Asch

Kidney Diseases; Nephrology

• Hybrid Revision of Dysfunctional Aneurysmal Arteriovenous FistulasKostiuk V, Chen J, Dahl N, Turner J, Chaar C. Hybrid Revision of Dysfunctional Aneurysmal Arteriovenous Fistulas. Vascular And Endovascular Surgery 2023, 57: 909-913. PMID: 37300698, DOI: 10.1177/15385744231183488.
• Risk Factors for Common Kidney Stones Are Correlated with Kidney Function Independent of Stone Composition.Simmons K, Simmons K, Simmons K, Nair H, Nair H, Nair H, Phadke M, Motamedinia P, Singh D, Montgomery T, Montgomery T, Dahl N. Risk Factors for Common Kidney Stones Are Correlated with Kidney Function Independent of Stone Composition. American Journal Of Nephrology 2023, 1-1. PMID: 37253348, DOI: 10.1159/000531046.
• Experiences of Patients on Maintenance Dialysis During the COVID-19 Pandemic: A Survey StudyNoce E, Brereton L, Zorzanello M, Aklilu A, Anders E, Bernal M, Sundararajan A, Dahl N, Kodali R, Patel D. Experiences of Patients on Maintenance Dialysis During the COVID-19 Pandemic: A Survey Study. Kidney Medicine 2023, 100673. PMCID: PMC10186967, DOI: 10.1016/j.xkme.2023.100673.
• Dialysis Patient Experiences During the COVID-19 Pandemic: A Survey StudyNoce E, Brereton L, Zorzanello M, Aklilu A, Anders E, Bernal M, Sundararajan A, Dahl N, Kodali R, Patel D. Dialysis Patient Experiences During the COVID-19 Pandemic: A Survey Study. Kidney Medicine 2023, 5: 100673. PMID: 37305377, PMCID: PMC10186967, DOI: 10.1016/j.xkme.2023.100673.
• Kidney cysts in patients with HOGA1 variants.Patel D, Page N, Dahl N. Kidney cysts in patients with HOGA1 variants. Clinical Nephrology 2023, 99: 260-264. PMID: 36928260, DOI: 10.5414/cn110939.
• Pharmacologic Management of Autosomal Dominant Polycystic Kidney DiseaseAckley W, Dahl N, Park M. Pharmacologic Management of Autosomal Dominant Polycystic Kidney Disease. Advances In Kidney Disease And Health 2023, 30: 228-235. PMID: 37088525, DOI: 10.1053/j.akdh.2023.02.002.
• Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney DiseaseGulati A, Dahl N, Hartung E, Clark S, Moudgil A, Goodwin J, Somlo S. Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease. Kidney360 2023, 4: 387-392. PMID: 36706243, PMCID: PMC10103195, DOI: 10.34067/kid.0000000000000064.
• Metabolic Evaluation and Prevention of Kidney Stone DiseaseDahl N, Goldfarb D. Metabolic Evaluation and Prevention of Kidney Stone Disease. 2022, 322-331. DOI: 10.1002/9781119105954.ch61.
• Perspectives on Drug Development in Early ADPKDMekahli D, Womack H, Dahl NK. Perspectives on Drug Development in Early ADPKD. Clinical Journal Of The American Society Of Nephrology 2022, 17: 1555-1558. PMID: 35998975, PMCID: PMC9528262, DOI: 10.2215/cjn.05190422.
• A Practical Guide to Genetic Testing for Kidney Disorders of Unknown EtiologyAron AW, Dahl NK, Besse W. A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology. Kidney360 2022, 3: 1640-1651. PMID: 36245662, PMCID: PMC9528385, DOI: 10.34067/kid.0007552021.
• Design and Basic Characteristics of a National Patient-Powered Registry in ADPKDHoover E, Perrone RD, Rusconi C, Benson B, Dahl NK, Gitomer B, Manelli A, Mrug M, Park M, Seliger SL, Phadnis MA, Thewarapperuma N, Watnick TJ. Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD. Kidney360 2022, 3: 1350-1358. PMID: 36176661, PMCID: PMC9416821, DOI: 10.34067/kid.0002372022.
• Genetic Diseases Associated with Tubulointerstitial NephritisWolf M, Besse W, Bleyer A, Dahl N. Genetic Diseases Associated with Tubulointerstitial Nephritis. 2022, 139-160. DOI: 10.1007/978-3-030-93438-5_11.
• Chapter 36 Nutritional prevention and treatment of urinary tract stones* * We are indebted to Dr. Marvin Grieff and Dr. David Bushinsky who wrote the previous edition of this chapter.Dahl N, Goldfarb D. Chapter 36 Nutritional prevention and treatment of urinary tract stones* * We are indebted to Dr. Marvin Grieff and Dr. David Bushinsky who wrote the previous edition of this chapter. 2022, 685-697. DOI: 10.1016/b978-0-12-818540-7.00046-x.
• An Unusual Cause of AKI in a Kidney Transplant RecipientMalhotra D, Dahl NK. An Unusual Cause of AKI in a Kidney Transplant Recipient. Kidney360 2021, 2: 1869-1870. PMID: 35373005, PMCID: PMC8785853, DOI: 10.34067/kid.0004332021.
• An Unusual Cause of Peritoneal Dialysis Catheter DysfunctionSundararajan A, Dahl NK, Latich I. An Unusual Cause of Peritoneal Dialysis Catheter Dysfunction. Kidney360 2021, 2: 1540-1541. PMID: 35373106, PMCID: PMC8786129, DOI: 10.34067/kid.0001762021.
• Association of AKI-D with Urinary Findings and Baseline eGFR in Hospitalized COVID-19 PatientsPatel DM, Phadke M, Dai F, Simonov M, Dahl NK, Kodali R. Association of AKI-D with Urinary Findings and Baseline eGFR in Hospitalized COVID-19 Patients. Kidney360 2021, 2: 1215-1224. PMID: 35369662, PMCID: PMC8676386, DOI: 10.34067/kid.0001612021.
• Examining the Role of Novel CKD Therapies for the ADPKD PatientPatel DM, Dahl NK. Examining the Role of Novel CKD Therapies for the ADPKD Patient. Kidney360 2021, 2: 1036-1041. PMID: 35373079, PMCID: PMC8791369, DOI: 10.34067/kid.0007422020.
• IgA vasculitis complicated by acute kidney failure with thrombotic microangiopathy: successful use of eculizumabPatel DM, Cantley L, Moeckel G, Dahl NK, Luciano R. IgA vasculitis complicated by acute kidney failure with thrombotic microangiopathy: successful use of eculizumab. Journal Of Nephrology 2021, 34: 2141-2145. PMID: 34019254, DOI: 10.1007/s40620-021-01028-8.
• Mayo Imaging Classification May Be Useful in Determining the Need for Nephrectomy in ADPKD.Rosenberg S, Virmani S, Klarman S, Santovasi S, Dai F, Dahl NK. Mayo Imaging Classification May Be Useful in Determining the Need for Nephrectomy in ADPKD. Kidney360 2021, 2: 325-330. PMID: 35373011, PMCID: PMC8740992, DOI: 10.34067/kid.0003902020.
• Long-Term Safety of Tolvaptan in ADPKD: Where Do We Stand?Patel DM, Dahl NK. Long-Term Safety of Tolvaptan in ADPKD: Where Do We Stand? Clinical Journal Of The American Society Of Nephrology 2020, 16: 3-5. PMID: 33376103, PMCID: PMC7792649, DOI: 10.2215/cjn.17981120.
• Clinical Applications of Genetic Discoveries in Kidney Transplantation: a Review.Marin EP, Cohen E, Dahl N. Clinical Applications of Genetic Discoveries in Kidney Transplantation: a Review. Kidney360 2020, 1: 300-305. PMID: 35372915, PMCID: PMC8809267, DOI: 10.34067/kid.0000312019.
• Technical and Ethical Challenges in the Care of an Independent Nonagenarian with Critical Limb IschemiaFereydooni, A, Dahl, N, Ochoa Chaar C. Technical and Ethical Challenges in the Care of an Independent Nonagenarian with Critical Limb Ischemia. Archives Of Clinical And Medical Case Reports 2020, 04 DOI: 10.26502/acmcr.96550178.
• Intraoperative Ultrasound Guidance for Banding of an Arteriovenous Fistula Causing High Cardiac Output Heart FailureTurner AD, Chen M, Dahl N, Scoutt L, Dardik A, Ochoa Chaar C. Intraoperative Ultrasound Guidance for Banding of an Arteriovenous Fistula Causing High Cardiac Output Heart Failure. Annals Of Vascular Surgery 2019, 66: 665.e5-665.e8. PMID: 31863947, DOI: 10.1016/j.avsg.2019.12.011.
• Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventionsLee SR, Zhuo H, Zhang Y, Dahl N, Dardik A, Ochoa Chaar CI. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions. Journal Of Vascular Surgery 2019, 72: 603-610.e1. PMID: 31843298, DOI: 10.1016/j.jvs.2019.09.059.
• Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKDGulati A, Sevillano AM, Praga M, Gutierrez E, Alba I, Dahl NK, Besse W, Choi J, Somlo S. Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD. Kidney International Reports 2019, 5: 103-108. PMID: 31922066, PMCID: PMC6943786, DOI: 10.1016/j.ekir.2019.09.004.
• Nephrolithiasis in the ElderlyDahl N, Goldfarb D. Nephrolithiasis in the Elderly. 2019, 201-212. DOI: 10.1007/978-3-030-18711-8_14.
• VESS26. Risk Factors and Safe Contrast Volume Thresholds for Acute Renal Failure After Peripheral Vascular InterventionsLee S, Zhuo H, Zhang Y, Dahl N, Dardik A, Chaar C. VESS26. Risk Factors and Safe Contrast Volume Thresholds for Acute Renal Failure After Peripheral Vascular Interventions. Journal Of Vascular Surgery 2019, 69: e71-e72. DOI: 10.1016/j.jvs.2019.04.053.
• IP155. Intraoperative Ultrasound Guidance for Banding of an Arteriovenous Fistula Causing High Cardiac Output Heart FailureTurner A, Chaar C, Dardik A, Dahl N, Scoutt L, Chen M. IP155. Intraoperative Ultrasound Guidance for Banding of an Arteriovenous Fistula Causing High Cardiac Output Heart Failure. Journal Of Vascular Surgery 2019, 69: e151-e152. DOI: 10.1016/j.jvs.2019.04.201.
• Inherited glomerular diseases in the gilded age of genomic advancementsGulati A, Dahl N, Tufro A. Inherited glomerular diseases in the gilded age of genomic advancements. Pediatric Nephrology 2019, 35: 959-968. PMID: 31049720, PMCID: PMC7184048, DOI: 10.1007/s00467-019-04266-y.
• In Reply to ‘TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features’Gulati A, Dahl N. In Reply to ‘TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD Is in Fact a Case of RVCL-S Presenting With Renal Features’. American Journal Of Kidney Diseases 2019, 73: 893-894. PMID: 30846257, DOI: 10.1053/j.ajkd.2019.01.014.
• Revisiting racial differences in ESRD due to ADPKD in the United StatesMurphy EL, Dai F, Blount KL, Droher ML, Liberti L, Crews DC, Dahl NK. Revisiting racial differences in ESRD due to ADPKD in the United States. BMC Nephrology 2019, 20: 55. PMID: 30764782, PMCID: PMC6376748, DOI: 10.1186/s12882-019-1241-1.
• Simple renal cysts and bovine aortic arch: markers for aortic diseaseBrownstein AJ, Bin Mahmood SU, Saeyeldin A, Velasquez Mejia C, Zafar MA, Li Y, Rizzo JA, Dahl NK, Erben Y, Ziganshin BA, Elefteriades JA. Simple renal cysts and bovine aortic arch: markers for aortic disease. Open Heart 2019, 6: e000862. PMID: 30774963, PMCID: PMC6350752, DOI: 10.1136/openhrt-2018-000862.
• A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanChebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. Journal Of The American Society Of Nephrology 2018, 29: 2458-2470. PMID: 30228150, PMCID: PMC6171265, DOI: 10.1681/asn.2018060590.
• TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD—A Novel PresentationGulati A, Bale AE, Dykas DJ, Bia MJ, Danovitch GM, Moeckel GW, Somlo S, Dahl NK. TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD—A Novel Presentation. American Journal Of Kidney Diseases 2018, 72: 895-899. PMID: 29941221, DOI: 10.1053/j.ajkd.2018.05.006.
• Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction MonitoringRauniyar N, Yu X, Cantley J, Voss EZ, Belcher J, Colangelo CM, Stone KL, Dahl N, Parikh C, Lam TT, Cantley LG. Quantification of Urinary Protein Biomarkers of Autosomal Dominant Polycystic Kidney Disease by Parallel Reaction Monitoring. Proteomics Clinical Applications 2018, 12: e1700157. PMID: 29573172, PMCID: PMC6736530, DOI: 10.1002/prca.201700157.
• Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney DiseaseMurphy EL, Droher ML, DiMaio MS, Dahl NK. Preimplantation Genetic Diagnosis Counseling in Autosomal Dominant Polycystic Kidney Disease. American Journal Of Kidney Diseases 2018, 72: 866-872. PMID: 29606500, DOI: 10.1053/j.ajkd.2018.01.048.
• Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant polycystic kidney disease and decreases with tolvaptan treatmentLee Y, Blount KL, Dai F, Thompson S, Scher JK, Bitterman S, Droher M, Herzog EL, Moeckel G, Karihaloo A, Dahl NK. Semaphorin 7A in circulating regulatory T cells is increased in autosomal-dominant polycystic kidney disease and decreases with tolvaptan treatment. Clinical And Experimental Nephrology 2018, 22: 906-916. PMID: 29453607, DOI: 10.1007/s10157-018-1542-x.
• Loss of kAE1 expression in collecting ducts of end-stage kidneys from a family with SLC4A1 G609R-associated distal renal tubular acidosisVichot AA, Zsengellér ZK, Shmukler BE, Adams ND, Dahl NK, Alper SL. Loss of kAE1 expression in collecting ducts of end-stage kidneys from a family with SLC4A1 G609R-associated distal renal tubular acidosis. Clinical Kidney Journal 2016, 10: 135-140. PMID: 28638614, PMCID: PMC5469557, DOI: 10.1093/ckj/sfw074.
• Simple Renal Cysts as Markers of Thoracic Aortic DiseaseZiganshin BA, Theodoropoulos P, Salloum MN, Zaza KJ, Tranquilli M, Mojibian HR, Dahl NK, Fang H, Rizzo JA, Elefteriades JA. Simple Renal Cysts as Markers of Thoracic Aortic Disease. Journal Of The American Heart Association 2016, 5: e002248. PMID: 26746998, PMCID: PMC4859353, DOI: 10.1161/jaha.115.002248.
• Effect of the decrease in dialysate sodium in pediatric patients on chronic hemodialysisMarsenic O, Anderson M, Couloures KG, Hong WS, Hall E, Dahl N. Effect of the decrease in dialysate sodium in pediatric patients on chronic hemodialysis. Hemodialysis International 2015, 20: 277-285. PMID: 26663617, DOI: 10.1111/hdi.12384.
• Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic EfficacyAlam A, Dahl NK, Lipschutz JH, Rossetti S, Smith P, Sapir D, Weinstein J, McFarlane P, Bichet DG. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy. American Journal Of Kidney Diseases 2015, 66: 564-576. PMID: 25960302, DOI: 10.1053/j.ajkd.2015.01.030.
• SP884INTERDIALYTIC WEIGHT GAIN IS NOT THE MAIN DETERMINANT OF HYPERTENSION IN PEDIATRIC HEMODIALYSISMarsenic O, Anderson M, Couloures K, Dahl N. SP884INTERDIALYTIC WEIGHT GAIN IS NOT THE MAIN DETERMINANT OF HYPERTENSION IN PEDIATRIC HEMODIALYSIS. Nephrology Dialysis Transplantation 2015, 30: iii668-iii668. DOI: 10.1093/ndt/gfv203.22.
• SP888EFFECT OF DIALYSATE SODIUM ON FLUID BALANCE, BLOOD PRESSURE AND SERUM SODIUM IN CHILDREN ON MAINTENANCE HEMODIALYSISMarsenic O, Anderson M, Couloures K, Dahl N. SP888EFFECT OF DIALYSATE SODIUM ON FLUID BALANCE, BLOOD PRESSURE AND SERUM SODIUM IN CHILDREN ON MAINTENANCE HEMODIALYSIS. Nephrology Dialysis Transplantation 2015, 30: iii669-iii669. DOI: 10.1093/ndt/gfv203.26.
• CT Urography for the Diagnosis of Medullary Sponge KidneyKoraishy FM, Ngo TT, Israel GM, Dahl NK. CT Urography for the Diagnosis of Medullary Sponge Kidney. American Journal Of Nephrology 2014, 39: 165-170. PMID: 24531190, DOI: 10.1159/000358496.
• Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and managementLuciano RL, Dahl NK. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management. Nephrology Dialysis Transplantation 2013, 29: 247-254. PMID: 24215018, DOI: 10.1093/ndt/gft437.
• Acute kidney injury in a patient with sarcoidosis: hypercalciuria and hypercalcemia leading to calcium phosphate deposition.Manjunath V, Moeckel G, Dahl NK. Acute kidney injury in a patient with sarcoidosis: hypercalciuria and hypercalcemia leading to calcium phosphate deposition. Clinical Nephrology 2013, 80: 151-5. PMID: 23845267, DOI: 10.5414/cn107258.
• Cystic Kidney Disease in a Patient With Systemic Toxicity From Long-term d-Penicillamine UseKoraishy FM, Cohen RA, Israel GM, Dahl NK. Cystic Kidney Disease in a Patient With Systemic Toxicity From Long-term d-Penicillamine Use. American Journal Of Kidney Diseases 2013, 62: 806-809. PMID: 23796907, DOI: 10.1053/j.ajkd.2013.04.017.
• Evaluation of urine biomarkers of kidney injury in polycystic kidney diseaseParikh CR, Dahl NK, Chapman AB, Bost JE, Edelstein CL, Comer DM, Zeltner R, Tian X, Grantham JJ, Somlo S. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney International 2012, 81: 784-790. PMID: 22258321, PMCID: PMC3319327, DOI: 10.1038/ki.2011.465.
• Resolution of proteinuria in a patient with focal segmental glomerulosclerosis following BiPAP initiation for obesity hypoventilation syndrome.Hall IE, Kashgarian M, Moeckel GW, Dahl NK. Resolution of proteinuria in a patient with focal segmental glomerulosclerosis following BiPAP initiation for obesity hypoventilation syndrome. Clinical Nephrology 2012, 77: 62-5. PMID: 22185970, DOI: 10.5414/cn106859.
• Should Living Kidney Donor Candidates with Impaired Fasting Glucose Donate?Vigneault CB, Asch WS, Dahl NK, Bia MJ. Should Living Kidney Donor Candidates with Impaired Fasting Glucose Donate? Clinical Journal Of The American Society Of Nephrology 2011, 6: 2054-2059. PMID: 21784837, DOI: 10.2215/cjn.03370411.
• Recurrent flank pain from ‘lobster claw’Singanamala S, Krishnamoorthy S, Perazella MA, Dahl NK. Recurrent flank pain from ‘lobster claw’. Clinical Kidney Journal 2011, 4: 274-275. PMID: 25949502, PMCID: PMC4421448, DOI: 10.1093/ndtplus/sfr032.
• Thrombotic Microangiopathy and Renal Failure Exacerbated by ε-Aminocaproic AcidMutter WP, Stillman IE, Dahl NK. Thrombotic Microangiopathy and Renal Failure Exacerbated by ε-Aminocaproic Acid. American Journal Of Kidney Diseases 2008, 53: 346-350. PMID: 18805613, DOI: 10.1053/j.ajkd.2008.07.023.
• Deficient HCO 3 - Transport in an AE1 Mutant with Normal Cl- Transport Can be Rescued by Carbonic Anhydrase II Presented on an Adjacent AE1 Protomer*Dahl NK, Jiang L, Chernova MN, Stuart-Tilley AK, Shmukler BE, Alper SL. Deficient HCO 3 - Transport in an AE1 Mutant with Normal Cl- Transport Can be Rescued by Carbonic Anhydrase II Presented on an Adjacent AE1 Protomer*. Journal Of Biological Chemistry 2003, 278: 44949-44958. PMID: 12933803, DOI: 10.1074/jbc.m308660200.
• The AE gene family of Cl/HCO3- exchangers.Alper SL, Darman RB, Chernova MN, Dahl NK. The AE gene family of Cl/HCO3- exchangers. Journal Of Nephrology 2002, 15 Suppl 5: s41-53. PMID: 12027221.
• A second complementation class of cholesterol transport mutants with a variant Niemann-Pick type C phenotype.Dahl NK, Daunais MA, Liscum L. A second complementation class of cholesterol transport mutants with a variant Niemann-Pick type C phenotype. Journal Of Lipid Research 1994, 35: 1839-49. PMID: 7852861.
• Abnormal regulation of low density lipoprotein-sensitive events in a cholesterol transport mutant.Dahl NK, Gutheil WG, Liscum L. Abnormal regulation of low density lipoprotein-sensitive events in a cholesterol transport mutant. The Journal Of Biological Chemistry 1993, 268: 16979-86. PMID: 8349588.
• Isolation and characterization of Chinese hamster ovary cells defective in the intracellular metabolism of low density lipoprotein-derived cholesterol.Dahl NK, Reed KL, Daunais MA, Faust JR, Liscum L. Isolation and characterization of Chinese hamster ovary cells defective in the intracellular metabolism of low density lipoprotein-derived cholesterol. The Journal Of Biological Chemistry 1992, 267: 4889-96. PMID: 1537866.
• Hairpin and duplex formation in DNA fragments CCAATTTTGG, CCAATTTTTTGG, and CCATTTTTGG: a proton NMR study.Pramanik P, Kanhouwa N, Kan LS. Hairpin and duplex formation in DNA fragments CCAATTTTGG, CCAATTTTTTGG, and CCATTTTTGG: a proton NMR study. Biochemistry 1988, 27: 3024-31. PMID: 3401464, DOI: 10.1021/bi00408a054.